CHARLOTTE, N.C., May 6, 2020 /PRNewswire/ -- NN, Inc., (NASDAQ: NNBR) a diversified industrial company, today announced that in response to the COVID-19 pandemic and the urgent need for personal protective equipment, Paragon Medical, a division of NN Life Sciences headquartered in Pierceton, Indiana, has designed and released an intubation shield for healthcare workers. The intubation shield provides a barrier between the healthcare professional and the patient during intubation and extubation procedures to reduce exposure to aerosolized airborne contaminants.
Paragon Medical, an FDA-registered medical device provider, teamed up with Solvay Specialty Polymers in Alpharetta, Georgia on the project. The intubation shield is manufactured using medical grade materials that will withstand full cleaning, disinfection, and repeated autoclaving. Additionally, the shield is collapsible for storage and ease of cleaning and disinfecting.
"I am extremely proud of the team who worked on the project. To have developed a product that contributes to the safety of the clinicians who are risking so much during this tough time, is something that we take a lot of pride in," said Rick Stetler, Group Vice President of Operations, NN Life Sciences. "Our designers worked closely with Solvay on the selection of Udel® P-1700 polysulfone (PSU), an ISO 10993 biocompatible, transparent polymer that can be repeatedly disinfected and sterilized. With their technical support and expedited lead-times on the material, the project went from concept to release in under two weeks. We are already receiving positive feedback from the field and facilities who are requesting more."
About NN, Inc. NN, Inc., a diversified industrial company, combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Charlotte, North Carolina, NN has 50 facilities in North America, Europe, South America and China.
About Solvay Solvay is an advanced materials and specialty chemicals company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers worldwide in many diverse end markets. Solvay is headquartered in Brussels with around 24,500 employees in 61 countries.
Except for specific historical information, many of the matters discussed in this press release may express or imply projections of revenues or expenditures, statements of plans and objectives or future operations or statements of future economic performance. These, and similar statements, are forward-looking statements concerning matters that involve risks, uncertainties and other factors which may cause the actual performance of NN, Inc. and its subsidiaries to differ materially from those expressed or implied by this discussion. All forward-looking information is provided by the Company pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "assumptions", "target", "guidance", "outlook", "plans", "projection", "may", "will", "would", "expect", "intend", "estimate", "anticipate", "believe", "potential" or "continue" (or the negative or other derivatives of each of these terms) or similar terminology. Factors which could materially affect actual results include, but are not limited to: general economic conditions and economic conditions in the industrial sector, disruptions in the Company's businesses and global economies and other impacts from the coronavirus outbreak pandemic, inventory levels, regulatory compliance costs and the Company's ability to manage these costs, start-up costs for new operations, debt reduction, competitive influences, risks that current customers will commence or increase captive production, risks of capacity underutilization, quality issues, availability and price of raw materials, currency and other risks associated with international trade, the Company's dependence on certain major customers, and the successful implementation of the global growth plan including development of new products. Similarly, statements made herein and elsewhere regarding strategic review and pending and completed transactions are also forward-looking statements, including statements relating to the future performance and prospects of an acquired business, the expected benefits of an acquisition on the Company's future business and operations and the ability of the Company to successfully integrate recently acquired businesses.
For additional information concerning such risk factors and cautionary statements, please see the section titled "Risk Factors" in the Company's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2019. Except as required by law, we undertake no obligation to update or revise any forward-looking statements we make in our press releases, whether as a result of new information, future events or otherwise.